import type { Metadata } from "next";
import Link from "next/link";
import PageLayout from "../../../components/PageLayout";
import PageHeader from "../../../components/PageHeader";
import ContentSection from "../../../components/ContentSection";
import Prose from "../../../components/Prose";
import Reveal from "../../../components/Reveal";
import PageCTA from "../../../components/PageCTA";

export const metadata: Metadata = {
  title: "HPRA compliance: a technology guide for pharma manufacturers | COGO",
  description: "How to build the technology infrastructure your pharmaceutical operation needs for HPRA compliance - from validated ERP systems to electronic batch records and regulatory submissions.",
};

export default function HpraComplianceGuidePage() {
  return (
    <PageLayout>
      <PageHeader eyebrow="Blog" title="HPRA compliance: a technology guide for pharmaceutical manufacturers" subtitle="Laurence Phelan - 23 March 2026" />

      <ContentSection withBorder>
        <Prose>
          <p>The Health Products Regulatory Authority (HPRA) sets the rules for pharmaceutical manufacturing in Ireland. If your systems cannot prove compliance, your products do not ship. It really is that simple.</p>
          <p>This guide is not about the HPRA itself - you can read their own site for that. Instead, it covers the technology decisions you need to get right so that HPRA inspections, regulatory submissions, and ongoing compliance become a manageable part of your operation rather than a constant source of anxiety.</p>
        </Prose>
      </ContentSection>

      <ContentSection withBorder>
        <Prose>
          <h2>What is the HPRA and why does it matter to your IT team?</h2>
          <p>The HPRA is Ireland's regulatory body responsible for the safety, quality, and efficacy of medicines, medical devices, and other health products. It operates under EU legislation including Directive 2001/83/EC and Regulation (EU) No 536/2014 for clinical trials.</p>
          <p>For your technology team, the HPRA matters because every inspection now includes a thorough review of your computerised systems. According to the HPRA's own annual report for 2023, 98% of manufacturing site inspections included an assessment of data integrity and computerised system controls. Your IT infrastructure is no longer a back-office concern - it is front and centre in every regulatory interaction.</p>
        </Prose>
      </ContentSection>

      <ContentSection withBorder>
        <Prose>
          <h2>HPRA regulatory requirements that affect your systems</h2>
          <p>Several HPRA requirements have direct implications for your technology stack. Ignore any of these and you are inviting observations, or worse, warning letters.</p>
          <h3>Data integrity (ALCOA+ principles)</h3>
          <p>Every piece of data your systems generate must be Attributable, Legible, Contemporaneous, Original, and Accurate - plus Complete, Consistent, Enduring, and Available. In practical terms, this means your systems need:</p>
          <ul>
            <li><strong>Audit trails</strong> that cannot be disabled or modified by users</li>
            <li><strong>Electronic signatures</strong> compliant with EU Annex 11</li>
            <li><strong>Access controls</strong> with role-based permissions</li>
            <li><strong>Backup and archival</strong> procedures that maintain data accessibility for the full retention period (typically the product shelf life plus one year, or at least five years)</li>
          </ul>
          <h3>EU Annex 11 (computerised systems)</h3>
          <p>Annex 11 of the EU GMP Guide is the cornerstone regulation for any computerised system in a pharmaceutical environment. Key requirements include:</p>
          <ul>
            <li>Formal risk assessments for all computerised systems</li>
            <li>Documented user requirement specifications</li>
            <li>Validation proportionate to system risk</li>
            <li>Periodic reviews (typically annual) of system compliance</li>
            <li>Business continuity planning for critical systems</li>
          </ul>
          <h3>Serialisation and track-and-trace</h3>
          <p>The EU Falsified Medicines Directive (2011/62/EU) requires unique identifiers on every saleable unit. Your systems must generate, store, and report serialisation data to the European Medicines Verification System (EMVS). Since February 2019, this has been mandatory - and the HPRA actively enforces it.</p>
          <h3>Electronic regulatory submissions</h3>
          <p>The HPRA accepts (and increasingly expects) electronic submissions via the EU Common Technical Document (eCTD) format. Your document management and regulatory affairs systems need to produce compliant eCTD output.</p>
        </Prose>
      </ContentSection>

      <ContentSection withBorder>
        <Prose>
          <h2>Technology infrastructure for HPRA compliance</h2>
          <p>Building the right technology foundation is not about buying the most expensive system. It is about ensuring every layer of your infrastructure can demonstrate compliance when an inspector asks.</p>
          <h3>Your ERP as the compliance backbone</h3>
          <p>Your Enterprise Resource Planning system sits at the centre of your compliance infrastructure. A properly configured <Link href="/industries/pharmaceutical/">ERP system for pharmaceutical manufacturing</Link> should handle:</p>
          <ul>
            <li><strong>Batch record management</strong> - electronic batch records that enforce process steps, capture data in real time, and prevent unauthorised changes</li>
            <li><strong>Material traceability</strong> - full lot tracking from raw material receipt through to finished product release</li>
            <li><strong>Quality management</strong> - CAPA, deviation management, change control, and OOS investigations, all within a single system of record</li>
            <li><strong>Supplier qualification</strong> - approved vendor lists with qualification status, audit schedules, and document management</li>
          </ul>
          <h3>Laboratory Information Management Systems (LIMS)</h3>
          <p>Your LIMS needs to integrate tightly with your ERP. Test results should flow automatically into batch records, with any OOS result triggering workflows in your quality management module. The HPRA has made it abundantly clear that manual data transfer introduces unacceptable data integrity risks.</p>
          <h3>Document management systems</h3>
          <p>A validated document management system (DMS) is non-negotiable. SOPs, batch records, validation protocols, and regulatory submissions all need version control, electronic approval workflows, and controlled distribution. According to a 2024 ISPE survey, 73% of pharmaceutical manufacturers cited document management as the area most frequently examined during regulatory inspections.</p>
          <h3>Manufacturing execution systems</h3>
          <p>For complex manufacturing operations, a Manufacturing Execution System (MES) bridges the gap between your ERP and the shop floor. It provides real-time process monitoring, enforces manufacturing instructions, and captures granular production data that your ERP typically cannot.</p>
        </Prose>
      </ContentSection>

      <ContentSection withBorder>
        <Prose>
          <h2>How ERP supports regulatory submissions</h2>
          <p>Your ERP is not just a compliance record-keeping tool - it actively supports the regulatory submission process.</p>
          <h3>Product registration data</h3>
          <p>Your ERP holds the master data for every product: formulations, bill of materials, process parameters, and approved suppliers. When preparing a Marketing Authorisation Application (MAA) or a variation submission, this data needs to be accurate, current, and retrievable at speed.</p>
          <h3>Stability data management</h3>
          <p>ICH Q1A stability studies generate enormous volumes of data over months and years. Your ERP or integrated LIMS must store, trend, and report this data in formats the HPRA accepts. Manual tracking in spreadsheets is a red flag for inspectors.</p>
          <h3>Annual product quality reviews</h3>
          <p>The HPRA expects annual product quality reviews (APQRs) that analyse batch data, deviations, complaints, stability results, and process changes. An ERP with strong reporting capabilities can generate the bulk of an APQR automatically, reducing the weeks of manual effort that many manufacturers still endure.</p>
          <h3>Pharmacovigilance reporting</h3>
          <p>Post-market safety reporting requires integration between your ERP (for product and batch identification), your pharmacovigilance database, and the EudraVigilance system. Automated data flows reduce reporting timelines and error rates.</p>
        </Prose>
      </ContentSection>

      <ContentSection withBorder>
        <Prose>
          <h2>Validation: the make-or-break requirement</h2>
          <p>No system goes live in a regulated pharmaceutical environment without validation. The GAMP 5 framework (ISPE's Guide for a Risk-Based Approach to Compliant GxP Computerised Systems) is the industry standard, and the HPRA expects you to follow it.</p>
          <p>Your validation approach should include:</p>
          <ol>
            <li><strong>Risk assessment</strong> - classify each system by GxP impact using GAMP 5 categories</li>
            <li><strong>Validation planning</strong> - a validation master plan (VMP) covering all computerised systems</li>
            <li><strong>IQ/OQ/PQ protocols</strong> - Installation, Operational, and Performance Qualification</li>
            <li><strong>Traceability matrix</strong> - linking user requirements to test cases and test results</li>
            <li><strong>Periodic review</strong> - annual assessments of system compliance, change history, and incident trends</li>
          </ol>
          <p>For more detail on this critical topic, read our guide to <Link href="/resources/blog/computer-system-validation-pharma/">computer system validation for pharmaceutical ERP</Link>.</p>
        </Prose>
      </ContentSection>

      <ContentSection withBorder>
        <Prose>
          <h2>Getting started: a practical checklist</h2>
          <p>If you are reviewing your technology infrastructure for HPRA compliance, start here:</p>
          <ol>
            <li><strong>Inventory your systems</strong> - list every computerised system that touches GxP data, including spreadsheets</li>
            <li><strong>Classify by risk</strong> - use GAMP 5 categories to prioritise validation effort</li>
            <li><strong>Assess data integrity</strong> - audit each system against ALCOA+ principles</li>
            <li><strong>Review integrations</strong> - map data flows between systems and identify any manual transfer points</li>
            <li><strong>Check audit trails</strong> - confirm that every GxP system has audit trails enabled and that they meet Annex 11 requirements</li>
            <li><strong>Plan your remediation</strong> - prioritise gaps by inspection risk and business impact</li>
          </ol>
        </Prose>
      </ContentSection>

      <ContentSection withBorder>
        <Prose>
          <h2>Frequently asked questions</h2>
          <h3>Does the HPRA accept cloud-hosted systems?</h3>
          <p>Yes. The HPRA follows the EMA's guidance on cloud computing, which permits cloud-hosted GxP systems provided you can demonstrate that the cloud provider meets appropriate security, data integrity, and access control standards. You will need a qualified supplier assessment and a clear data processing agreement.</p>
          <h3>How often does the HPRA inspect computerised systems?</h3>
          <p>The HPRA conducts routine GMP inspections on a risk-based cycle, typically every two to three years for manufacturing sites. Computerised systems are reviewed as part of every routine inspection, and the HPRA can also conduct targeted data integrity inspections at any time.</p>
          <h3>Can we use spreadsheets for GxP data?</h3>
          <p>Technically yes, but they are high-risk. The HPRA and PIC/S guidance both flag spreadsheets as a significant data integrity concern because they lack audit trails, access controls, and version management. If you must use spreadsheets, they need to be validated, access-controlled, and regularly reviewed. Better to replace them with validated systems wherever possible.</p>
          <h3>What happens if the HPRA finds our systems non-compliant?</h3>
          <p>Consequences range from written observations (which require a formal CAPA response) to warning letters, suspension of manufacturing authorisation, or product recalls. In 2023, the HPRA issued 14 GMP non-compliance statements, several of which cited data integrity and computerised system failures as contributing factors.</p>
        </Prose>
      </ContentSection>

      <ContentSection withBorder>
        <Reveal>
          <p className="text-[15px] text-muted leading-relaxed"><strong>Your systems are your compliance evidence.</strong> If you need independent guidance on building a technology infrastructure that satisfies HPRA requirements, <Link href="/contact/" className="text-accent underline underline-offset-4 decoration-accent/30 hover:decoration-accent/60 transition-colors">talk to our pharmaceutical consulting team</Link>.</p>
        </Reveal>
      </ContentSection>

      <PageCTA />
    </PageLayout>
  );
}
